PRP Concepts, Inc. — SEC Form D Filing

PRP Concepts, Inc. filed an SEC Form D on August 6, 2026, reporting $1.50M raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
August 6, 2026
Amount reported
$1.50M
Industry
Medical Devices
Website
https://prpconcepts.com/

What the company does

Securities: Equity, Debt. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Chronic wounds disrupt the natural healing cycle, leading to delayed recovery and increased complications for patients. Current standard treatments often fall short in addressing these complex wounds, which affect a significant portion of the population.

Solution

PRP Concepts™ developed the CASCADE® Autologous Platelet System, an FDA 510(k)-cleared medical device that creates a Platelet-Rich Fibrin Membrane (PRFM) from a patient's own blood. This membrane provides sustained growth factor release directly to the wound, optimizing the body's ability to heal and accelerating wound closure.

Why now

There is an urgent need for more effective and cost-efficient treatments for chronic wounds, particularly diabetic foot ulcers, due to the increasing prevalence of diabetes and the high economic and health burden of these conditions.

Verdict

This cleared because it presented a tangible product in an established market with a clear, unmet medical need, not because it promised a novel technological breakthrough. Investors were implicitly betting on the company's ability to navigate regulatory hurdles and capture market share from existing, less effective treatments. The limited upside stemmed from the highly competitive and reimbursement-dependent nature of the medical device space, where long sales cycles and entrenched solutions create significant adoption barriers.

Source: SEC EDGAR Form D filing